by Timileyin Ajuwon | Nov 26, 2024 | MS TODAY, Research
We are excited to share the latest research insights from the Buffalo Neuroimaging Analysis Center (BNAC) presented at the ECTRIMS 2024 meeting in Copenhagen, Denmark. This year, BNAC showcased six compelling abstracts highlighting advancements in understanding...
by Timileyin Ajuwon | Aug 28, 2024 | MS TODAY, MS Treatments, Research
From the moment someone is diagnosed with multiple sclerosis, a maze of barriers awaits. But in York Region, such people aren’t alone. Other residents who also have MS, an auto-immune disease affecting the central nervous system, volunteer to help them buy...
by Peter | May 5, 2022 | Research, VISION
Living Well with MS | National Multiple Sclerosis Society (nationalmssociety.org) Emotional Well-Being Emotional Well-Being | National Multiple Sclerosis Society (nationalmssociety.org) Spiritual Well-Being Spiritual Well-Being | National Multiple Sclerosis Society...
by Peter | May 5, 2022 | Research, VISION
Multiple Sclerosis NewsMay 5, 2022 Top Headlines Multiple Sclerosis: Study With Twins Untangles Environmental and Genetic Influences Feb. 16, 2022 — Researchers have studied the immune system of pairs of monozygotic twins to identify the influence of the...
by Peter | May 1, 2022 | Research, VISION
By Becky UphamMedically Reviewed by Samuel Mackenzie, MD, PhDReviewed: February 14, 2022 n many chronic conditions, the way the disease will progress over months or years is relatively predictable. That’s not the case with multiple sclerosis (MS); while some people...
by Peter | Apr 11, 2022 | Research
A drug that treats relapsing-remitting multiple sclerosis – a form of multiple sclerosis that accounts for around 85 percent of people with the condition – has been revealed to reverse some of the damage caused by the disease. This revelation may have implications for...